The National Health Insurance House announced on Friday that it has identified and proposed to the Ministry of Health a series of additional criteria for modifying the compensation level of evaluated medicines, so that the real impact on the personal contribution due by the insured is as moderate as possible, and specified that vulnerable persons will not be affected, maintaining the current compensation level for them. The CNAS reply comes in the context of information appearing in the public